神经系统疾病神经炎症的PET成像
本文综述了PET成像在体内定量神经炎症方面的应用,指出PET适合量化神经炎症并可能区分神经免疫反应的组分,但可靠定量仍面临多种障碍。尽管存在挑战,PET研究一致发现神经免疫反应与阿尔茨海默病等脑部疾病的病理生理相关,组织学研究也开始阐明部分疾病中PET信号变化的含义。
要点
- PET可定量神经炎症并有望区分神经免疫反应组分,但可靠定量仍存障碍
- PET研究一致发现神经免疫反应与阿尔茨海默病等脑部疾病的病理生理相关
- 神经炎症PET尚无确立的临床应用,但新靶点在研且可能用于药物开发
核心结论
- PET成像适合量化神经炎症并有望区分神经免疫反应组分,但可靠定量仍存多种障碍。
- PET研究一致发现神经免疫反应与阿尔茨海默病等脑部疾病的病理生理相关。
- 神经炎症PET尚无确立的临床应用,但新靶点在研,少量且增多的研究提示其可能用于药物开发。
研究设计与样本
- 本文为综述,检索范围未在原文中报告。
主要发现
- PET研究一致发现神经免疫反应与阿尔茨海默病等脑部疾病的病理生理相关。
- 组织学研究已开始阐明部分疾病中PET信号变化的含义。
- 少量且增多的研究提示神经炎症PET可能在药物开发中发挥作用。
临床怎么用
- 神经炎症PET目前尚无确立的临床应用,暂不能作为常规临床决策依据。
- 未来需进一步研究PET信号变化背后的细胞机制、免疫反应在神经疾病中的作用及其治疗性调控方式。
局限性
- 神经炎症PET的可靠定量仍存在多种障碍。
- 神经炎症PET尚无确立的临床应用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A growing need exists for reliable in-vivo measurement of neuroinflammation to better characterise the inflammatory processes underlying various diseases and to inform the development of novel therapeutics that target deleterious glial activity. PET is well suited to quantify neuroinflammation and has the potential to discriminate components of the neuroimmune response. However, there are several obstacles to the reliable quantification of neuroinflammation by PET imaging. Despite these challenges, PET studies have consistently identified associations between neuroimmune responses and pathophysiology in brain disorders such as Alzheimer's disease. Tissue studies have also begun to clarify the meaning of changes in PET signal in some diseases. Furthermore, although PET imaging of neuroinflammation does not have an established clinical application, novel targets are under investigation and a small but growing number of studies have suggested that this imaging modality could have a role in drug development. Future studies are needed to further improve our knowledge of the cellular mechanisms that underlie changes in PET signal, how immune response contributes to neurological disease, and how it might be therapeutically modified.
引用
- Kreisl WC, Kim MJ, Coughlin JM, et al. PET imaging of neuroinflammation in neurological disorders. Lancet Neurol. 2020. PMID: 33098803. doi:10.1016/S1474-4422(20)30346-X
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。